DaVita (DVA)
(Delayed Data from NYSE)
$137.95 USD
+1.89 (1.39%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $137.99 +0.04 (0.03%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth B Momentum A VGM
DaVita HealthCare (DVA) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$141.64 | $150.00 | $123.50 | 4.10% |
Price Target
Based on short-term price targets offered by seven analysts, the average price target for DaVita HealthCare comes to $141.64. The forecasts range from a low of $123.50 to a high of $150.00. The average price target represents an increase of 4.1% from the last closing price of $136.06.
Analyst Price Targets (7 )
Broker Rating
DaVita HealthCare currently has an average brokerage recommendation (ABR) of 2.86 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 2.86 a month ago based on seven recommendations.
Of the seven recommendations deriving the current ABR, one is Strong Buy, representing 14.29% of all recommendations. A month ago, Strong Buy represented 14.29%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/DVA.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 5 | 5 | 5 | 5 | 5 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.86 | 2.86 | 2.86 | 2.86 | 2.86 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
5/15/2024 | Truist Securities | David S Macdonald | Hold | Hold |
3/27/2024 | Not Identified | Not Identified | Hold | Hold |
3/5/2024 | Not Identified | Not Identified | Not Available | Hold |
2/15/2024 | UBS | Aj Rice | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.86 |
ABR (Last week) | 2.86 |
# of Recs in ABR | 7 |
Average Target Price | $141.64 |
LT Growth Rate | 13.60% |
Industry | Medical - Outpatient and Home Healthcare |
Industry Rank by ABR | 63 of 252 |
Current Quarter EPS Est: | 2.47 |